Skip to main content
. 2021 May 19;9(5):576. doi: 10.3390/biomedicines9050576
AD Alzheimer’s disease
amyloid β
mTOR mechanistic target of rapamycin kinase
SGLT2 sodium glucose cotransporter 2
APP/PS1 mice double transgenic mouse model of Alzheimer’s disease over expressing amyloid precursor protein, encoding the Swedish mutations at amino acids 595/596 and an exon-9-deleted human PS1
Tg2576 mice transgenic mouse model, which express a 695-aa residue splice form of human amyloid precursor protein modified by the Swedish Familial AD double mutation K670N-M671L
3xTg-AD mice triple-transgenic mouse model harboring PS1M146V, APPSwe, and tauP301L transgenes
ATP adenosine triphosphate
MAPT microtubule associated protein tau
ROS reactive oxygen species
IDE insulin-degrading enzymes
APP amyloid precursor protein
TZDs thiazolidinediones
GLP1 glucagon-like peptide-1
DPP-4 dipeptidyl peptidase-4
IGF-1 insulin-like growth factor-1
PS1 presenilin 1
PS 2 presenilin 2
APOE Apolipoprotein E
PPARs peroxisome proliferator-activated receptors
AChE acetylcholinesterase
AMPK adenosine 5′mmonophosphate-activated protein kinase
PPARs peroxisome proliferator-activated receptors
PI3K phosphatidylinositol-3-OH kinase
IRS-2 insulin receptor-2
NLRP3 nod-like receptor pyrin domain containing 3